F-group (family)
5054.1.1.4 Ion_trans,Ion_trans_N
Ligands and drugs
104
Member domains
40
with ligand contacts (≤ 4 Å)
38.5% of members
12
with DrugDomain annotations
11.5% of members
4
with a DrugBank compound
3.8% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5054.1.1.4 belongs to X-group 5054 Voltage-gated ion channels, which binds 10.4 ligand superclasses per 20 proteins, broader than 97% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02144 | PIE | 1,2-diacyl-sn-glycero-3-phosphoinositol | 4 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| PCW | 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 16 |
| 3PE | 1,2-Distearoyl-sn-glycerophosphoethanolamine | 8 |
| PC1 | 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 8 |
| PFL | 2,6-BIS(1-METHYLETHYL)PHENOL | 8 |
| HGmetal | MERCURY (II) ION | 4 |
| PIE | 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoinositol | 4 |
| UNX | UNKNOWN ATOM OR ION | 4 |
| VNZ | Ivabradine | 4 |
| VX9 | 4-[[(2~{S},4~{a}~{R},6~{S},8~{a}~{S})-6-[(4~{S},5~{R})-4-[(2~{S})-butan-2-yl]-5,9-dimethyl-decyl]-4~{a}-methyl-2,3,4,5,6,7,8,8~{a}-octahydro-1~{H}-naphthalen-2-yl]oxy]-4-oxidanylidene-butanoic acid | 4 |
| VXI | 3-[[(3~{S})-1-[2-(3,4-dimethoxyphenyl)ethyl]piperidin-3-yl]methyl]-7,8-dimethoxy-2,5-dihydro-1~{H}-3-benzazepin-4-one | 4 |